Policy & Advocacy

The administration's proposed Compact offers preferential access to federal research funding in exchange for adopting policy commitments such as prohibiting consideration of race or sex in admissions, capping international student enrollment, and restricting diversity, equity, and inclusion initiatives. Several top US universities have rejected it.

Outcomes of the Symposium’s proceedings will be used to inform the development of FASEB positions and responses to Requests for Information, as well as its advocacy on Capitol Hill.

Join FASEB’s Advocacy Town Hall Meetings—a recurring, virtual space where researchers and advocates come together twice a month (first and third Tuesday from noon to 1 pm ET).

Research!America has created a timeline of administrative actions since January 20, 2025 that have impacted medical research.

How long this shutdown will last depends on reaching a bipartisan agreement on the continuing resolution, since it will take more time to sign the FY 2026 spending bills into law.

FASEB, of which GSA is a member, issued a statement encouraging Congress and the president to reach an immediate agreement to end the government shutdown and pass a short-term continuing resolution to temporarily fund federal agencies while negotiations continue on the unfinished FY 2026 appropriations bills.

The Trump administration rescinded a grant that maintained FlyBase, a pillar of global basic research, as part of its broader $2.2 billion funding cuts at Harvard.

FASEB, of which GSA is a member, highlighted the risks associated with capping or eliminating the ability for researchers to utilize NIH grant funds to publish their work in reputable, peer-reviewed journals.

The report highlights 53 options for streamlining regulatory oversight, covering topics ranging from development of grant proposals and award management and tracking financial conflicts of interest to oversight of research involving human and nonhuman animal subjects.

NIH is launching its Biosafety Modernization Initiative – a comprehensive effort to modernize and strengthen biosafety policies, practices, and oversight to keep pace with the evolving risks posed by today’s rapidly advancing science and technology.

The NIH released its implementation strategy in response to Executive Order on "Restoring Gold Standard Science."